Pulse Biosciences vs Flyte Aviation
PLSE and VJET side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PLSE and VJET compare
Pulse Biosciences is the larger company, worth 507 times as much as Flyte Aviation ($3.6B against $7.1M).
Pulse Biosciences grew revenue faster over the last twelve months (1637% versus 219% for Flyte Aviation).
Flyte Aviation keeps more of each dollar of sales as profit, with a net margin of −679% compared with −5604% at Pulse Biosciences.
Flyte Aviation scores higher on the StockData Score (10 against 8 for Pulse Biosciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PLSE | VJET |
|---|---|---|
| Size and price | ||
| Market cap | $3.6B | $7.1M |
| Share price | $50.44 | $0.493 |
| Change, 1 year | 236% | −97.9% |
| Change, 5 years | 137% | −100.0% |
| Beta (5Y) | 1.24 | 1.02 |
| Employees | 116 | 17 |
| StockData Score | ||
| Total score | 8 | 10 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 2 | 2 |
| Performance score | 0 | 1 (better) |
| Health score | 6 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2408× | 3.7× (better) |
| P/B | 19.6× | 0.4× (better) |
| FCF yield | −1.8% (better) | −132% |
| Fair value | – | $3.47 |
| Margin of safety | – | 85.8% |
| Growth | ||
| Revenue growth (TTM) | 1637% (better) | 219% |
| Revenue growth, 5Y average | – | 25.9% |
| Profitability | ||
| Gross margin | 26.8% | 47.7% (better) |
| Operating margin | −5821% | −1000% (better) |
| Net margin | −5604% | −679% (better) |
| FCF margin | −4264% | −489% (better) |
| Return on equity | −60.6% (better) | −107% |
| Return on invested capital | – | −140% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 14.35 (better) | 0.19 |
| Altman Z-score | 115.81 (better) | −13.75 |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 15.0% | – |
| Held by insiders | 71.2% | 7.1% |
| Insider net buying, 12 months | $23.9M | – |
| Short interest, % of float | 14.1% | 0.64% |
Go deeper
- PLSE stock overview
- PLSE income statement
- PLSE valuation and score
- VJET stock overview
- VJET income statement
- VJET valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.